- Home
- TIO 2021 Symposium - Streamlining TAVI: Delivering the Best Patients Outcomes and Efficient Pathways
TIO 2021 Symposium - Streamlining TAVI: Delivering the Best Patients Outcomes and Efficient Pathways
- Intervention
- Structural Heart Disease
Available Credit:
- 1.00
Course Published On:
Course Expiry Date:
Overview
In this satellite symposium, hear from leading faculty as they discuss the patient management considerations for TAVI and review cases that highlight patient management and procedure efficiencies. This symposium is part of Transcatheter Interventions Online 2021, a world-class virtual event dedicated to transcatheter treatment strategies for coronary and structural heart disease.
Support Statement
This programme is supported by unrestricted educational grants from Medtronic. The scientific programme has not been influenced in any way by the sponsor.
Disclosure
In compliance with EBAC / EACCME guidelines, all speakers/chairpersons participating in this programme have disclosed or indicated potential conflicts of interest which might cause a bias in the presentations.
The Organising Committee/Course Director is responsible for ensuring that all potential conflicts of interest relevant to the event are declared to the audience prior to the CME activities.
Terms & Conditions
Radcliffe Education requires contributors to our CME programmes to disclose any relevant financial relationships that have occurred within the past 12 months that could create a conflict of interest. These will be identified in the faculty section if applicable.
The session of ‘Streamlining TAVI: Delivering the Best Patient Outcomes and Efficient Pathway’ is accredited by the European Board for Accreditation in Cardiology (EBAC) for 1 hour of external CME credits.
Each participant should claim only those hours of credit that have actually been spent in the educational activity. EBAC works according to the quality standards of the European Accreditation Council for Continuing Medical Education (EACCME), which is an institution of the European Union of Medical Specialists (UEMS).
Through an agreement between the European Board for Accreditation in Cardiology and the American Medical Association, physicians may convert EBAC External CME credits to AMA PRA Category 1 Credits™. Information on the process to convert EBAC credit to AMA credit can be found on the AMA website.
Instructions to Participants
There is no fee for taking part in this online learning activity.
Activities are designed to be completed within 60 minutes and must be completed by the registered user. Physicians should only claim credits for time spent on the activity. To successfully earn credit, participants must complete the activity in full in the indicated time frame.
To complete the course and claim certification participants must:
- Read the course outline information supplied and complete pre-test questions if supplied prior to starting the activity. Users must read and study the activity in its entirety before completing the post-test questions.
- Your results will be automatically saved and if a pass score is achieved (where applicable), you may be eligible to claim credit for the activity and receive a certificate of completion.
Target Audience
- Electrophysiologists
- Arrhythmologists
- General Cardiologists
- Cardiac catheterization technologists and technicians
- Physiologists
- Device Implanting Specialist
Learning Objectives
Upon completion of this activity, participants will be able to:
- Discuss the patient management considerations for TAVI
- Discuss resource utilization and examples that may improve procedure efficiencies
- Review TAVI cases that highlight patient management and procedure efficiencies
Module |
Title |
Duration |
Speakers |
|---|---|---|---|
| 1 | Introduction | Mohamed Abdel-Wahab (Germany) | |
| 2 | Procedural Considerations for Better Patient Outcomes | Christopher Malkin (Leeds, UK) | |
| 3 | Q&A and Discussion | Mohamed Abdel-Wahab (Germany) Christopher Malkin (Leeds, UK) Kendra J Grubb (Atlanta, US) Stefan Toggweiler (Lucerne, Switzerland) | |
| 4 | Optimising Patient Pathways: LEAN TAVI Concept | Stefan Toggweiler (Lucerne, Switzerland) | |
| 5 | Q&A and Discussion | Mohamed Abdel-Wahab (Germany) Christopher Malkin (Leeds, UK) Kendra J Grubb (Atlanta, US) Stefan Toggweiler (Lucerne, Switzerland) | |
| 6 | TAVI Case Reviews | Kendra J Grubb (Atlanta, US) | |
| 7 | Q&A and Discussion | Mohamed Abdel-Wahab (Germany) Christopher Malkin (Leeds, UK) Kendra J Grubb (Atlanta, US) Stefan Toggweiler (Lucerne, Switzerland) | |
| 8 | Summary | Mohamed Abdel-Wahab (Germany) |
Procedural Considerations for Better Patient Outcomes
Duration:
Speakers: Christopher Malkin (Leeds, UK)
Q&A and Discussion
Duration:
Speakers: Mohamed Abdel-Wahab (Germany) Christopher Malkin (Leeds, UK) Kendra J Grubb (Atlanta, US) Stefan Toggweiler (Lucerne, Switzerland)
Optimising Patient Pathways: LEAN TAVI Concept
Duration:
Speakers: Stefan Toggweiler (Lucerne, Switzerland)
Q&A and Discussion
Duration:
Speakers: Mohamed Abdel-Wahab (Germany) Christopher Malkin (Leeds, UK) Kendra J Grubb (Atlanta, US) Stefan Toggweiler (Lucerne, Switzerland)
Q&A and Discussion
Duration:
Speakers: Mohamed Abdel-Wahab (Germany) Christopher Malkin (Leeds, UK) Kendra J Grubb (Atlanta, US) Stefan Toggweiler (Lucerne, Switzerland)
Related Courses
- 1.00
Published:
Learning objectives
- Recall TAVI SMART trial data and the implications on clinical practice
- Describe novel valve designs and the impact on long-term performance
- Develop an expert-led approach to improving equitable access to TAVI
- 1.00
Published:
Learning objectives
- Evaluate the factors influencing coronary access in different valve designs
- Formulate strategies to optimise coronary access based on valve characteristics
- Evaluate the role of valve design in reducing pacemaker implantation rates and enhancing future coronary access
- Learn the step-by-step process for achieving optimum implant depth during TAVI
- Apply guidelines and best practices for achieving and confirming optimum implant depth in TAVI procedures
- 1.00
Published:
Learning objectives
- Recall current and predicted trends in TAVI with respect to preserving coronary access
- Consider determining factors for choosing valves in low risk populations
- Discuss solutions for maximising valve durability and haemodynamics and for treating degenerated TAVI
- 1.00
Published:
Learning objectives
- Compare the utility of repair and replacement valve technology in mitral regurgitation
- Individualise valve choice for aortic regurgitation based on valve durability and patient features
- Recall the utility and limitations of specialty balloons
- Evaluate emerging approaches to the treatment of complex left main and other coronary bifurcation lesions
- Discuss the impact of PCI on top of optimal medical therapy in ischaemic left ventricular systolic dysfunction
- Identify suitable patients for interatrial shunting
- Discuss the merits of alternative antiplatelet strategies to DAPT in ACS and CCS following PCI
- 1.00
Published:
Learning objectives
- Compare the utility of repair and replacement valve technology in mitral regurgitation
- Individualise valve choice for aortic regurgitation based on valve durability and patient features
- Recall the utility and limitations of specialty balloons
- Evaluate emerging approaches to the treatment of complex left main and other coronary bifurcation lesions
- Discuss the impact of PCI on top of optimal medical therapy in ischaemic left ventricular systolic dysfunction
- Identify suitable patients for interatrial shunting
- 1.00
Published:
Learning objectives
- Compare the utility of repair and replacement valve technology in mitral regurgitation
- Individualise valve choice for aortic regurgitation based on valve durability and patient features
- Recall the utility and limitations of specialty balloons
- Evaluate emerging approaches to the treatment of complex left main and other coronary bifurcation lesions
- Discuss the impact of PCI on top of optimal medical therapy in ischaemic left ventricular systolic dysfunction
- Identify suitable patients for interatrial shunting
- 1.00
Published:
Learning objectives
- Compare the utility of repair and replacement valve technology in mitral regurgitation
- Individualise valve choice for aortic regurgitation based on valve durability and patient features
- Recall the utility and limitations of specialty balloons
- Evaluate emerging approaches to the treatment of complex left main and other coronary bifurcation lesions
- Discuss the impact of PCI on top of optimal medical therapy in ischaemic left ventricular systolic dysfunction
- Identify suitable patients for interatrial shunting
- Discuss the merits of alternative antiplatelet strategies to DAPT in ACS and CCS following PCI
- 1.00
Published:
Learning objectives
- Compare the utility of repair and replacement valve technology in mitral regurgitation
- Individualise valve choice for aortic regurgitation based on valve durability and patient features
- Recall the utility and limitations of specialty balloons
- Evaluate emerging approaches to the treatment of complex left main and other coronary bifurcation lesions
- Discuss the impact of PCI on top of optimal medical therapy in ischaemic left ventricular systolic dysfunction
- Identify suitable patients for interatrial shunting
- Discuss the merits of alternative antiplatelet strategies to DAPT in ACS and CCS following PCI
- 1.00
Published:
Learning objectives
- Compare the utility of repair and replacement valve technology in mitral regurgitation
- Individualise valve choice for aortic regurgitation based on valve durability and patient features
- Recall the utility and limitations of specialty balloons
- Evaluate emerging approaches to the treatment of complex left main and other coronary bifurcation lesions
- Discuss the impact of PCI on top of optimal medical therapy in ischaemic left ventricular systolic dysfunction
- Identify suitable patients for interatrial shunting
- Discuss the merits of alternative antiplatelet strategies to DAPT in ACS and CCS following PCI
- 1.00
Published:
Learning objectives
- Compare the utility of repair and replacement valve technology in mitral regurgitation
- Individualise valve choice for aortic regurgitation based on valve durability and patient features
- Recall the utility and limitations of specialty balloons
- Evaluate emerging approaches to the treatment of complex left main and other coronary bifurcation lesions
- Discuss the impact of PCI on top of optimal medical therapy in ischaemic left ventricular systolic dysfunction
- Identify suitable patients for interatrial shunting
- Discuss the merits of alternative antiplatelet strategies to DAPT in ACS and CCS following PCI